approval · primary record
CEFEPIME HYDROCHLORIDE
3 approval events · latest 2026-06-25
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-06-25 |
| Approval events | 3 |
| Brand | CEFEPIME IN PLASTIC CONTAINER |
| Sponsor | BAXTER HLTHCARE |
| Route | INJECTION |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-06-25 | FDA | NDA | CEFEPIME IN PLASTIC CONTAINER | BAXTER HLTHCARE | INJECTION |
| 2026-05-29 | FDA | NDA | ZAYNICH | WOCKHARDT BIO AG | INTRAVENOUS |
| 2026-04-07 | FDA | NDA | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER | B BRAUN | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:30:49.463Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:cefepime-hydrochloride
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cefepime Hydrochloride · compound